News Room

One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks

Health Canada has recalled a single lot of Eli Lilly Glucagon, as it may be contaminated. The lot number is D239382A, expiry May 10, 2022. Please check your glucagon kits and return it to the pharmacy if you have a vial with this lot number. All other lot numbers are fine.  For more information, click here: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76507a-eng.php.

Manitoba implements expanded coverage for insulin pumps and advanced glucose monitors

This past spring, the province committed to providing public coverage for advanced glucose monitors, including continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) for people with T1D up to age 25. The commitment also included expanded coverage under the Manitoba Pediatric Insulin Pump Program by changing the eligible age limit from under 18 […]

BC Announces Coverage for Dexcom CGM Effective Today

“JDRF is grateful for the leadership the BC government has shown in taking this step towards Access for All and moving to cover continuous glucose monitoring under BC Pharmacare,” said Dave Prowten, President and CEO of JDRF Canada. British Columbia announced today that it will begin covering Dexcom G6 continuous glucose monitoring (CGM) for those […]

Virtual fundraiser unveiled in support of type 1 diabetes research

NEWS RELEASE TORONTO, ON — June 3, 2021 – The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that rallies the type 1 diabetes (T1D) community to unite and raise funds for T1D research. This year’s Walk is a family-friendly, virtual, and interactive event that will bring together […]

Government of Canada invests $35M in research and a national framework for diabetes

JDRF Canada is grateful to the Government of Canada for its commitment to honouring the centenary of the discovery of insulin in the 2021 federal budget. The budget proposes an investment of $35M for research into type 1 diabetes, surveillance and prevention, and to work towards the development of a national framework for diabetes. Continued […]

Manitoba and Saskatchewan Announce Expanded Coverage for Diabetes Technology

Wednesday, April 7, 2021, Toronto, ON – “JDRF Canada applauds this week’s provincial government announcements out of Saskatchewan and Manitoba, which are expanding access to insulin pumps and continuous and flash glucose monitoring devices for those living with type 1 diabetes,” says Dave Prowten, president and CEO, JDRF Canada. In the budget announced Tuesday on April […]

New Data on COVID-19 Outcomes in Children with T1D

Understanding how challenging and unpredictable the COVID-19 pandemic is, especially for those impacted by type 1 diabetes (T1D), JDRF Canada continues to ensure that you have the credible and reliable information you need to help you better navigate the various and complex issues that are constantly arising.

Donate | Donnez